PMID- 17030631 OWN - NLM STAT- MEDLINE DCOM- 20070124 LR - 20181113 IS - 0270-7306 (Print) IS - 1098-5549 (Electronic) IS - 0270-7306 (Linking) VI - 26 IP - 24 DP - 2006 Dec TI - Mammary tumorigenesis and metastasis caused by overexpression of insulin receptor substrate 1 (IRS-1) or IRS-2. PG - 9302-14 AB - Insulin receptor substrates (IRSs) are signaling adaptors that play a major role in the metabolic and mitogenic actions of insulin and insulin-like growth factors. Reports have recently noted increased levels, or activity, of IRSs in many human cancers, and some have linked this to poor patient prognosis. We found that overexpressed IRS-1 was constitutively phosphorylated in vitro and in vivo and that transgenic mice overexpressing IRS-1 or IRS-2 in the mammary gland showed progressive mammary hyperplasia, tumorigenesis, and metastasis. Tumors showed extensive squamous differentiation, a phenotype commonly seen with activation of the canonical beta-catenin signaling pathway. Consistent with this, IRSs were found to bind beta-catenin in vitro and in vivo. IRS-induced tumorigenesis is unique, given that the IRSs are signaling adaptors with no intrinsic kinase activity, and this supports a growing literature indicating a role for IRSs in cancer. This study defines IRSs as oncogene proteins in vivo and provides new models to develop inhibitors against IRSs for anticancer therapy. FAU - Dearth, Robert K AU - Dearth RK AD - Breast Cancer, Baylor College of Medicine and Methodist Hospital, Department of Medicine, Houston, TX 77030, USA. FAU - Cui, Xiaojiang AU - Cui X FAU - Kim, Hyun-Jung AU - Kim HJ FAU - Kuiatse, Isere AU - Kuiatse I FAU - Lawrence, Nicole A AU - Lawrence NA FAU - Zhang, Xiaomei AU - Zhang X FAU - Divisova, Jana AU - Divisova J FAU - Britton, Ora L AU - Britton OL FAU - Mohsin, Syed AU - Mohsin S FAU - Allred, D Craig AU - Allred DC FAU - Hadsell, Darryl L AU - Hadsell DL FAU - Lee, Adrian V AU - Lee AV LA - eng GR - R01DK52197/DK/NIDDK NIH HHS/United States GR - T32 CA090221/CA/NCI NIH HHS/United States GR - P01CA30195/CA/NCI NIH HHS/United States GR - T32 DK007696/DK/NIDDK NIH HHS/United States GR - P01 CA030195/CA/NCI NIH HHS/United States GR - DK07696/DK/NIDDK NIH HHS/United States GR - R01 DK052197/DK/NIDDK NIH HHS/United States GR - CA90221/CA/NCI NIH HHS/United States GR - R01 CA094118/CA/NCI NIH HHS/United States GR - R01CA94118/CA/NCI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20061009 PL - United States TA - Mol Cell Biol JT - Molecular and cellular biology JID - 8109087 RN - 0 (Adaptor Proteins, Signal Transducing) RN - 0 (IRS1 protein, human) RN - 0 (IRS2 protein, human) RN - 0 (Insulin Receptor Substrate Proteins) RN - 0 (Intracellular Signaling Peptides and Proteins) RN - 0 (Irs1 protein, mouse) RN - 0 (Irs2 protein, mouse) RN - 0 (Phosphoproteins) SB - IM MH - Adaptor Proteins, Signal Transducing/biosynthesis/genetics MH - Animals MH - Cell Line, Transformed MH - Female MH - Humans MH - Hyperplasia MH - Insulin Receptor Substrate Proteins MH - Intracellular Signaling Peptides and Proteins/*genetics/physiology MH - Lung Neoplasms/genetics/pathology/*secondary MH - Mammary Glands, Animal/pathology MH - Mammary Neoplasms, Experimental/*genetics/pathology MH - Mice MH - Mice, Transgenic MH - Neoplasm Metastasis/genetics/pathology MH - Phosphoproteins/*biosynthesis/*genetics/physiology MH - Signal Transduction/physiology PMC - PMC1698542 EDAT- 2006/10/13 09:00 MHDA- 2007/01/25 09:00 PMCR- 2007/04/01 CRDT- 2006/10/13 09:00 PHST- 2006/10/13 09:00 [pubmed] PHST- 2007/01/25 09:00 [medline] PHST- 2006/10/13 09:00 [entrez] PHST- 2007/04/01 00:00 [pmc-release] AID - MCB.00260-06 [pii] AID - 0260-06 [pii] AID - 10.1128/MCB.00260-06 [doi] PST - ppublish SO - Mol Cell Biol. 2006 Dec;26(24):9302-14. doi: 10.1128/MCB.00260-06. Epub 2006 Oct 9.